Potassium (1-(tert-butoxycarbonyl)azetidin-3-yl)trifluoroborate

97%

Reagent Code: #227520
fingerprint
CAS Number 1430219-73-0

science Other reagents with same CAS 1430219-73-0

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 263.1 g/mol
Formula C₈H₁₄BNO₂F₃-.K+
inventory_2 Storage & Handling
Storage -20°C, Inert Gas

description Product Description

Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct biologically active molecules. Its azetidine ring is valuable for enhancing metabolic stability and solubility in drug candidates. The tert-butoxycarbonyl (Boc) protecting group ensures compatibility with multi-step synthetic routes, allowing controlled deprotection and further functionalization. Commonly employed in the development of protease inhibitors, kinase inhibitors, and other therapeutic agents where small, rigid ring systems improve target binding and pharmacokinetic properties.

Available Sizes & Pricing

Size Availability Unit Price Quantity
250mg
10-20 days ฿6,000.00
1g
10-20 days ฿15,670.00
5g
10-20 days ฿63,670.00
10g
10-20 days ฿116,560.00
Potassium (1-(tert-butoxycarbonyl)azetidin-3-yl)trifluoroborate
No image available

Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct biologically active molecules. Its azetidine ring is valuable for enhancing metabolic stability and solubility in drug candidates. The tert-butoxycarbonyl (Boc) protecting group ensures compatibility with multi-step synthetic routes, allowing controlled deprotection and further functionalization. Commonly employed in the development of protease inhibitors, kinase inhibitors, and ot

Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct biologically active molecules. Its azetidine ring is valuable for enhancing metabolic stability and solubility in drug candidates. The tert-butoxycarbonyl (Boc) protecting group ensures compatibility with multi-step synthetic routes, allowing controlled deprotection and further functionalization. Commonly employed in the development of protease inhibitors, kinase inhibitors, and other therapeutic agents where small, rigid ring systems improve target binding and pharmacokinetic properties.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...